Home > Healthcare > Biotechnology > Biotechnology R&D > Cell Counting Market

Cell Counting Market Size

Report ID: GMI8496
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Cell Counting Market Size

Cell Counting Market size was valued at USD 11.7 billion in 2023 and is expected to grow at a CAGR of 6.6% between 2024 and 2032, owing to the rising incidence of chronic diseases such as HIV, measles, diphtheria, cancer, and blood disorders, prompting an intense need for precise cell counting in diagnosis, treatment monitoring, and research activities.

To get key market trends

Download Free Sample

For instance, according to UNAIDS data revealed that around 39 million individuals worldwide were living with HIV in 2022, with approximately 1.3 million new infections. Comparatively, in 2021, an estimated 1.5 million new HIV infections occurred. These escalating incidence rates underscore the imperative for accurate cell counting and diagnostic tests, thereby driving market growth.

Cell Counting Market Report Attributes
Report Attribute	Details
Base Year:	2023
Cell Counting Market Size in 2023:	USD 11.7 Billion
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	6.6%
2032 Value Projection:	USD 20.7 Billion
Historical Data for:	2018 - 2023
No. of Pages:	180
Tables, Charts & Figures:	466
Segments covered:	Product Type, Application, End-user, and Region
Growth Drivers:	Increasing incidence of chronic disease and blood disorders Growing government support for awareness and approval Increasing funding accelerated R&D efforts Escalated cell-therapy-based research Growing advancement in cell counting technologies
Pitfalls & Challenges:	Limitations of counting techniques High cost of advanced cell counting systems

Learn more about the key segments shaping this market

Download Free Sample

Cell counting refers to the process of quantifying the number of cells within a sample. In the context of the cell counting market, it involves the use of various techniques and instruments to accurately determine the concentration of cells in a given solution or suspension. These techniques can include manual counting using a hemocytometer, automated counting using cell counters, flow cytometry, or image-based analysis systems.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of cell counting reached USD 11.7 billion in 2023 and is set to expand at 6.6% CAGR over 2024-2032, led by the rising incidence of chronic diseases such as HIV, measles, diphtheria, cancer, and blood disorders.

The consumables and reagents segment is slated to depict substantial growth at 6.7% CAGR from 2024 to 2032, as they are essential in facilitating accurate and efficient cell counting processes.

North America accounted for 38% of the market share in 2023, attributed to a larger patient population, increased adoption of high-throughput flow cytometry and automated hematology analyzers in healthcare settings in the region.

Prominent cell counting companies include Abbott Laboratories, Agilent Technologies, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Biote, Instruments, Inc., ChemoMetec A/S, DeNovix, Merck KGaA, NanoEnTek Inc, Olympus Corporation, Sysmex Corporation, and Thermo Fisher Scientific Inc.